Synthetic Biology Governance Doctrine

Introduction

Synthetic Biology Governance Doctrine refers to a proposed legal framework that establishes principles for regulating the research, development, testing, production and commercial application of synthetic biological technologies. Its purpose is to balance scientific innovation with public health, environmental protection, human rights, national security and scientific accountability.

Synthetic biology involves designing, modifying or constructing biological organisms, genetic materials and cellular systems for specific purposes. Its applications include vaccine development, genetic engineering, disease treatment, agricultural improvement and industrial biotechnology.

However, these technologies may create risks such as accidental release of engineered organisms, genetic contamination, misuse of biological research and damage to biodiversity. Therefore, effective governance requires scientific supervision, biosafety assessment, transparent approvals and legal responsibility.

The term is not an independently recognised legal doctrine under Indian law. Its principles are derived from existing environmental, constitutional and biotechnology regulations.

Legal and Regulatory Framework in India

1. Environment (Protection) Act, 1986: Sections 3, 6 and 8 empower the Central Government to take environmental protection measures and regulate hazardous substances. This Act provides the statutory foundation for India's biotechnology biosafety regulations.

2. Biosafety Rules, 1989: These Rules regulate the manufacture, use, import, export and storage of hazardous microorganisms and genetically engineered organisms or cells. They also extend to relevant new gene technologies.

IndiaCode+1

3. Institutional Biosafety Committees (IBSCs): These committees supervise relevant biotechnology research, examine safety arrangements and monitor compliance with applicable biosafety requirements.

4. RCGM and GEAC: The Review Committee on Genetic Manipulation (RCGM), functioning under the Department of Biotechnology, monitors safety aspects of relevant research. The Genetic Engineering Appraisal Committee (GEAC) performs regulatory appraisal and approval functions, particularly concerning large-scale use and environmental release.

ibkp.dbt.gov.in+1

5. Recombinant DNA Research and Biocontainment Guidelines, 2017: These guidelines provide safety procedures, containment requirements and risk-management standards for relevant biotechnology research.

Important Case Laws

1. Vellore Citizens’ Welfare Forum v. Union of India (1996) 5 SCC 647

The Supreme Court recognised the precautionary principle and polluter-pays principle as essential elements of Indian environmental law. These principles require preventive action against serious environmental risks and place responsibility for environmental damage on those causing it.

2. M.C. Mehta v. Union of India (1987) 1 SCC 395

In the Oleum Gas Leak case, the Supreme Court established the principle of absolute liability for enterprises engaged in hazardous or inherently dangerous activities. This principle is relevant by analogy where biotechnology industries cause harm through unsafe biological operations.

3. Indian Council for Enviro-Legal Action v. Union of India (1996) 3 SCC 212

The Court held that industries responsible for environmental pollution must bear the cost of remedial measures. This judgment supports accountability for organisations whose biological activities cause environmental damage.

4. Gene Campaign v. Union of India, 2024 INSC 545

The Supreme Court delivered a split verdict concerning the environmental release of genetically modified mustard. The judgments examined biosafety assessment, scientific transparency, regulatory procedures and environmental protection. The case is relevant to synthetic biology governance because it highlights the importance of scientific and regulatory scrutiny of genetic technologies.

Indian Kanoon+1

Major Principles of Synthetic Biology Governance

Precautionary principle: Potential biological risks should be assessed before activities are permitted.

Scientific responsibility: Researchers must follow appropriate ethical and biosafety standards.

Environmental protection: Engineered organisms must be handled under suitable containment and monitoring procedures.

Human rights: Genetic privacy, bodily autonomy and human dignity must be protected.

Regulatory accountability: Government authorities must make transparent and scientifically justified decisions.

Corporate liability: Organisations responsible for biological or environmental harm should face appropriate legal consequences.

Conclusion

Synthetic Biology Governance Doctrine represents an emerging approach to regulating modern biological technologies through established legal principles. Although India has not enacted a separate statute recognising this doctrine, the Environment (Protection) Act, 1986, Biosafety Rules, 1989 and constitutional principles provide its legal foundation. Future legislation should establish clearer standards for genetic engineering, biological risk assessment, environmental release, research supervision and institutional accountability. The objective should be to promote scientific innovation while protecting human health, biodiversity and public welfare.

Note: The cited judgments establish general environmental and biotechnology-related principles. None directly recognises or decides a separate Synthetic Biology Governance Doctrine.